Posts - Bill - S 2372 340B PATIENTS Act of 2025
senate 07/22/2025 - 119th Congress
We are working to ensure that hospitals and health centers can reliably access discounted medicines through the 340B program, no matter where or how those drugs are dispensed. This bill clarifies that drug manufacturers cannot impose restrictions that limit patient access or the ability of covered entities to use contract pharmacies.
Congress.gov
S 2372 - 340B PATIENTS Act of 2025
Views
moderate 07/22/2025
Sounds like a decent balance between free market muscle and protecting public health—let’s see it work.
moderate 07/22/2025
If contracting pharmacies keep meds affordable and accessible, why tangle drugmakers up in red tape?
left-leaning 07/22/2025
Finally, a leash on drug companies trying to play gatekeeper to our health—patients first, profits last.
left-leaning 07/22/2025
No more shady restrictions; this bill puts community care back where it belongs: front and center.
right-leaning 07/22/2025
More rules on drugmakers? How about letting the market fix itself before Congress jumps in again.
right-leaning 07/22/2025
You want innovation? Start cutting back on these costly mandates, not shoving more regulations down everyone’s throat.
left-leaning 07/22/2025
Pharma can’t hold patients hostage—this bill makes sure meds reach those who need them, no ifs or buts.
moderate 07/22/2025
Drug discounts should help patients, not line pockets—this bill tries to draw that clear line.
right-leaning 07/22/2025
This bill sounds like government overreach dressed up as 'patient care'—who’s footing the bill anyway?